To answer this question, after 12 weeks of WD/CCl4 administration, the mice were treated with Marimastat (100 mg·kg−1·day−1), a potent TACE inhibitor, for 12 weeks (Fig. 5A). This evidence concerns the gene ADAM17 and Wilson disease.